BeyondSpring Inc. (BYSI) stock
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.60+0.00 (+0.03%)
Close on Nov 13, 2026Market cap $24.72MP/E –Yield –
BeyondSpring r&d expenses
Research and development expenses are spending on new products and technology.
BeyondSpring's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.56M, up 53.6% year over year. For fiscal 2025 it was $4.39M, up 66.0% from the year before. Over ten years it grew -3.5% a year on average. The highest annual figure on record is $88.93M in fiscal 2017.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.39M | +66.0% |
| FY2024 | Dec 31, 2024 | $2.64M | -63.6% |
| FY2023 | Dec 31, 2023 | $7.27M | -71.6% |
| FY2022 | Dec 31, 2022 | $25.58M | -30.6% |
| FY2021 | Dec 31, 2021 | $36.89M | -11.7% |
| FY2020 | Dec 31, 2020 | $41.79M | +33.3% |
| FY2019 | Dec 31, 2019 | $31.34M | -39.3% |
| FY2018 | Dec 31, 2018 | $51.62M | -42.0% |
| FY2017 | Dec 31, 2017 | $88.93M | +752.0% |
| FY2016 | Dec 31, 2016 | $10.44M | +66.1% |
| FY2015 | Dec 31, 2015 | $6.28M | +234.9% |
| FY2014 | Dec 31, 2014 | $1.88M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $973.00K | -2.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.08M | +23.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.47M | +212.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.04M | +67.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.00M | +20.9% |
| Q1 FY2025 | Mar 31, 2025 | $874.00K | +21.2% |
| Q4 FY2024 | Dec 31, 2024 | $472.00K | -91.8% |
| Q3 FY2024 | Sep 30, 2024 | $622.00K | -92.6% |
| Q2 FY2024 | Jun 30, 2024 | $829.00K | -92.7% |
| Q1 FY2024 | Mar 31, 2024 | $721.00K | -93.6% |
| Q4 FY2021 | Dec 31, 2021 | $5.79M | -31.3% |
| Q3 FY2021 | Sep 30, 2021 | $8.46M | -2.1% |
| Q2 FY2021 | Jun 30, 2021 | $11.33M | +2.8% |
| Q1 FY2021 | Mar 31, 2021 | $11.31M | -17.5% |
| Q4 FY2020 | Dec 31, 2020 | $8.42M | -33.0% |
| Q3 FY2020 | Sep 30, 2020 | $8.64M | +19.5% |
| Q2 FY2020 | Jun 30, 2020 | $11.03M | +112.0% |
| Q1 FY2020 | Mar 31, 2020 | $13.70M | +116.5% |
| Q4 FY2019 | Dec 31, 2019 | $12.58M | +1.2% |
| Q3 FY2019 | Sep 30, 2019 | $7.23M | -48.8% |
| Q2 FY2019 | Jun 30, 2019 | $5.20M | -52.7% |
| Q1 FY2019 | Mar 31, 2019 | $6.33M | -55.0% |
| Q4 FY2018 | Dec 31, 2018 | $12.43M | -15.5% |
| Q3 FY2018 | Sep 30, 2018 | $14.12M | -7.6% |
| Q2 FY2018 | Jun 30, 2018 | $10.99M | -9.8% |
| Q1 FY2018 | Mar 31, 2018 | $14.07M | -69.9% |
| Q4 FY2017 | Dec 31, 2017 | $14.70M | +386.4% |
| Q3 FY2017 | Sep 30, 2017 | $15.29M | +458.0% |
| Q2 FY2017 | Jun 30, 2017 | $12.19M | +282.5% |
| Q1 FY2017 | Mar 31, 2017 | $46.75M | +3043.7% |
| Q4 FY2016 | Dec 31, 2016 | $3.02M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.74M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.19M | – |
| Q1 FY2016 | Mar 31, 2016 | $1.49M | – |
See a number that looks wrong?